Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Urso | M | 60 | 10 years | |
| David Walsey | M | - | 11 years | |
| Charles Baltic | M | 63 | 13 years | |
| Fred Driscoll | M | 73 | 6 years | |
| Thomas Reynolds | M | 65 | 11 years | |
| Susan Alexander | F | 67 | 21 years | |
| Nick Glover | M | 55 | 11 years | |
| Richard Ghalie | M | 66 | 8 years | |
| Anne Frese | F | - | 2 years | |
| Eugene Park | M | - | 3 years | |
| Jason Sausser | M | - | 2 years | |
| Eric Deng | M | - | 3 years | |
| Caroline Ruiz | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Miller | M | 73 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 23 years |
| Jack Lief | M | 78 | 18 years | |
| John Dunn | M | 72 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 10 years |
| Robert Duggan | M | 79 | 7 years | |
| Phillip Schneider | M | 68 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 28 years |
| William Young | M | 79 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 11 years |
| Amit Munshi | M | 56 | 6 years | |
| Thomas M. Zech | M | 72 | 7 years | |
| Dominic P. Behan | M | 59 | 19 years | |
| William R. Rohn | M | 80 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 12 years |
| Robert W. Pangia | M | 72 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 24 years |
| Mahkam Zanganeh | M | 52 | 7 years | |
| James Tobin | M | 79 | 5 years | |
| Brian Drazba | M | 63 | 6 years | |
| Garry Neil | M | 70 | 5 years | |
| Mark Wiggins | M | 68 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 11 years |
| Craig M. Audet | M | 59 | 5 years | |
| Bryan Williams | M | 74 | 7 years | |
| Michael Kelly | M | 67 | 2 years | |
| Gilmore O’Neill | M | 59 | 15 years | |
| Jennifer Jarrett | F | 53 | 5 years | |
| Scott H. Bice | M | 81 | 15 years | |
| Sylvie Grégoire | M | 62 | 8 years | |
| Jayson Dallas | M | 56 | 5 years | |
| Ofir Moreno | M | - | 12 years | |
| Pete de Spain | M | - | 7 years | |
| Leah Cann | F | 63 | 7 years | |
| Michael LaBarre | M | 60 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 11 years |
| Christopher Cabell | M | 54 | 3 years | |
| Robert A. Hamm | M | 72 | 7 years | |
| Paul Clancy | M | 62 | 16 years | |
| Bill Welch | M | 62 |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | 4 years |
| Oliver Fetzer | M | 60 | 5 years | |
| Tamar Howson | F | 75 | 4 years | |
| William Rastetter | M | 75 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 17 years |
| Craig Eric Schneier | M | 76 | 8 years | |
| Kevan E. Clemens | M | 80 | 7 years | |
| Sujay Kango | M | 60 | 2 years | |
| Arturo Molina | M | 65 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 5 years |
| James N. Lowder | M | 74 | - | |
| Cheryl Cohen | F | 58 | 2 years | |
| Donald D. Belcher | M | 84 | 14 years | |
| Alan B. Glassberg | M | 87 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 12 years |
| Hutan Hashemi | M | 45 |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | 9 years |
| James L. Vincent | M | 84 | 12 years | |
| Bruce R. Ross | M | 83 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | 13 years |
| Randall E. Woods | M | 72 | 13 years | |
| Ben Harshbarger | M | 55 | 5 years | |
| John Cox | M | 61 | 14 years | |
| James Kelly | M | 58 | 5 years | |
| Timothy D. Hunt | M | - | 9 years | |
| Anne Cook | F | 62 | 13 years | |
| Michael Panzara | M | 57 | 8 years | |
| Maiken Keson-Brookes | F | 52 | 5 years | |
| William Mccarthy | M | - | 1 years | |
| Andrew Hirsch | M | 53 | 9 years | |
| Ken Bate | M | 73 | 6 years | |
| Michael Cloonan | M | 53 | 14 years | |
| Thomas F. Keller | M | 92 | - | |
| Paula Cobb | F | 51 | 13 years | |
| Barry Ticho | M | 64 | 13 years | |
| Alexey A. Lugovskoy | M | 51 | 9 years | |
| Joseph J. Kenny | M | - | 5 years | |
| Susie Melody | F | - | 2 years | |
| Evan M. Beckman | M | - | - | |
| Alfred Sandrock | M | 67 | 23 years | |
| Hans-Peter Hasler | M | 68 | 8 years | |
| Ted Llana | M | 60 | 7 years | |
| Michael Kauffman | M | 60 | 2 years | |
| Elan Ezickson | M | 60 | 9 years | |
| Nancy Simonian | M | 63 | 6 years | |
| Paul Aldridge | M | - | - | |
| Lawrence C. Best | M | 75 | - | |
| Michael Bonney | M | 65 | 6 years | |
| Alan Belzer | M | 91 | 10 years | |
| Jennifer A. Spinella | F | - | - | |
| Peter Kellogg | M | 67 | 4 years | |
| Alain J. Gilbert | M | - | 5 years | |
| Elizabeth Woo | F | 57 | 12 years | |
| Mary L. Good | M | 93 | 10 years | |
| John Maraganore | M | 60 | 10 years | |
| Steven Perrin | M | 59 | 5 years | |
| John Alam | M | 62 | 6 years | |
| Faheem Hasnain | M | 65 | 4 years | |
| Michael D. Kowolenko | M | 68 | - | |
| Joanne Quan | M | 60 | 2 years | |
| Robert Peach | M | 68 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christine Anna White
- Personal Network
